Michael H. Wu

A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

E. Cook, M. Ratain, F. Innocenti, 2005, Cancer research.

Inhibition of Nuclear Factor-KB Activity by Temozolomide Involves O 6 -Methylguanine-Induced Inhibition of p65DNA Binding

M. Dolan, R. Weichselbaum, D. Kufe, 2007 .

High Efficiency Electroporation of Human Umbilical Cord Blood CD34+ Hematopoietic Precursor Cells

M. Dolan, Michael H. Wu, Stephen L. Smith, 2001, Stem cells.

Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.

M. Dolan, R. Humerickhouse, B. Yan, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.

E. Cook, G. Rosner, Soma Das, 2004, Pharmacogenetics.

The Cytoplasmic N,n'-Diacetylchitobiase Gene From Vibrio Parahaemolyticus: Sequence Analysis, Protein Secretion, and Secretion System Development.

Michael H. Wu, 1996 .

Effect of O 6-Benzylguanine on Alkylating Agent-induced Toxicity and Mutagenicity in Chinese Hamster Ovary Cells Expressing Wild-Type and Mutant O 6-Alkylguanine-DNA Alkyltransferases 1

M. Dolan, A. Pegg, Yingna Cai, 2000 .

Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

M. Dolan, R. Weichselbaum, D. Kufe, 2007, Cancer research.

Advances in Brief Role of O 6-Alkylguanine-DNA Alkyltransferase in Protecting against Cyclophosphamide-induced Toxicity and Mutagenicity 1

M. Dolan, Yingna Cai, Michael H. Wu, 1999 .

Characterization of multiple promoters in the human carboxylesterase 2 gene.

E. Cook, Soma Das, Peixian Chen, 2003, Pharmacogenetics.

Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.

M. Dolan, M. Wu, Michael H. Wu, 1999, Cancer research.